Overview

Gonadotropin Releasing Hormone Antagonist in Treatment of Early-onset Severe Ovarian Hyperstimulation Syndrome

Status:
Completed

Trial end date:
2016-03-01

Target enrollment:

Participant gender:

Summary

Efficacy of the use of GnRH antagonist in treatment of those who develop early-onset severe ovarian hyperstimulation syndrome and had cancelled embryo transfer

Phase:

Phase 2

Details

Lead Sponsor:

Ain Shams University

Treatments:

Cetrorelix
Hormone Antagonists
Hormones